Y
Yan Wu
Researcher at Genentech
Publications - 77
Citations - 7333
Yan Wu is an academic researcher from Genentech. The author has contributed to research in topics: Antibody & Notch signaling pathway. The author has an hindex of 35, co-authored 72 publications receiving 6454 citations. Previous affiliations of Yan Wu include Hoffmann-La Roche.
Papers
More filters
Journal ArticleDOI
Therapeutic antibody targeting of individual Notch receptors
Yan Wu,Carol Cain-Hom,Lisa Choy,Thijs J. Hagenbeek,Gladys P. de Leon,Yongmei Chen,David Finkle,Rayna Venook,Xiumin Wu,John B. Ridgway,Dorreyah Schahin-Reed,Graham J. Dow,Amy L. Shelton,Scott Stawicki,Ryan J. Watts,Jeff Zhang,Robert Choy,Peter Howard,Lisa C. Kadyk,Minhong Yan,Jiping Zha,Christopher A. Callahan,Sarah G. Hymowitz,Christian W. Siebel +23 more
TL;DR: The studies emphasize the value of paralogue-specific antagonists in dissecting the contributions of distinct Notch receptors to differentiation and disease and reveal the therapeutic promise in targeting Notch1 and Notch2 independently.
Journal ArticleDOI
Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth
Qi Pan,Yvan Chanthery,Wei-Ching Liang,Scott Stawicki,Judy Mak,Nisha Rathore,Raymond K. Tong,Joe Kowalski,Sharon Yee,Glenn Pacheco,Sarajane Ross,Zhiyong Cheng,Jennifer Le Couter,Greg Plowman,Franklin Peale,Alexander W. Koch,Yan Wu,Anil Bagri,Marc Tessier-Lavigne,Ryan J. Watts +19 more
TL;DR: It is proposed that blocking NRP1 function inhibits vascular remodeling, rendering vessels more susceptible to anti-VEGF therapy, and generated two monoclonal antibodies that bind to the Sema- and VEGF-binding domains of N RP1.
Journal ArticleDOI
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy.
Qian Gong,Qinglin Ou,Shiming Ye,Wyne P. Lee,Jennine Cornelius,Lauri Diehl,Wei Yu Lin,Zhilan Hu,Yanmei Lu,Yongmei Chen,Yan Wu,Y. Gloria Meng,Peter Gribling,Zhonghua Lin,Kathy Nguyen,Thanhvien Tran,Yifan Zhang,Hugh Rosen,Flavius Martin,Andrew C. Chan +19 more
TL;DR: It is demonstrated that factors derived from the microenvironment, including signals from the B cell-activating factor belonging to the TNF family/BLyS survival factor, integrin-regulated homeostasis, and circulatory dynamics of B cells define distinct in vivo mechanism(s) and sensitivities of cells in anti-hCD20 mAb-directed therapies.
Journal ArticleDOI
PirB Is a Functional Receptor for Myelin Inhibitors of Axonal Regeneration
Jasvinder K. Atwal,Julie Pinkston-Gosse,Josh Syken,Scott Stawicki,Yan Wu,Carla J. Shatz,Carla J. Shatz,Marc Tessier-Lavigne +7 more
TL;DR: This work has found that paired immunoglobulin-like receptor B (PirB), which has been implicated in nervous system plasticity, is a high-affinity receptor for Nogo, MAG, and OMgp, and partially rescues neurite inhibition by Nogo66,MAG, OM gp, and myelin in cultured neurons.
Journal ArticleDOI
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies.
Gabriele Schaefer,Lauric Haber,Lisa Crocker,Steven Shia,Lily Shao,Donald Dowbenko,Klara Totpal,Anne Wong,Chingwei Vivian Lee,Scott Stawicki,Robyn Clark,Carter Fields,Gail Lewis Phillips,Rodney A. Prell,Dimitry M. Danilenko,Yvonne Franke,Jean-Philippe Stephan,Jiyoung Hwang,Yan Wu,Jenny Bostrom,Mark X. Sliwkowski,Germaine Fuh,Charles Eigenbrot +22 more
TL;DR: Compared with monospecific anti-HER antibodies, MEHD7945A was more broadly efficacious in multiple tumor models, showing that combined inhibition of EGFR and HER3 with a single antibody is beneficial.